Milestones
2024
Lee’s 30th Anniversary
2023
Featured in the “2022 Top 100 Chinese Chemical Pharmaceutical Companies”
Nadroparin Calcium Injection won bid in China’s eighth round of drug bulk-buying program
2022
Featured in the “2021 Top 100 Chinese Chemical Pharmaceutical Companies”
Officially launched the Flagship eStore on Ali’s and JD’s Platforms in March 2022.
2021
Successfully listed on the “2020 Top 100 Chinese Chemical Pharmaceutical Companies”
Zhaoke Ophthalmology Limited successfully listed on Main Board of the Stock Exchange of Hong Kong Limited (Stock code:6622) on 29 April 2021
2020
Successfully raised approximately US$145 million through the private placement of series B preferred shares of Zhaoke Ophthalmology Limited in October 2020
2019
Successfully raised approximately US$50 million through the private placement of series A preferred shares of China Ophthalmology Focus Limited in May 2019
Formation of Lee’s Pharmaceutical Taiwan Limited, registered and operated in Taiwan on 9 April 2019
2018
Completed the merger of CVie Therapeutics Limited with Windtree Therapeutics, Inc. in December 2018
2017
Establishment of China Ophthalmology Focus Limited
Completed the acquisition of majority of shares in Windtree Therapeutics, Inc. at a consideration of US$10 million in November 2017
Successfully carried out the reorganization of CVie Therapeutics Company Limited into two companies: CVie Therapeutics Limited for Taiwan business and CVie Therapeutics Company Limited for China business
Successfully raised approximately US$7.5 million through the private placement of series A preferred shares of CVie Therapeutics Limited in May 2017
2016
Nansha Facility obtained Manufacturing License for Tablet and Capsule on 30 June 2016
2015
Establishment of Guangzhou Zhaokang Hospital Company Limited and acquisition of the land parcel with a total site area of approximately 36,656 m² and with a total planned gross floor area of approximately 65,981m² specifically for medical and sanitary use in Nansha District, Guangzhou, China in September 2015
Formation of Zhaoke Pharmaceutical (Guangzhou) Company Limited, registered and operated in Nansha District, Guangzhou, China
Inclusion to various Hang Seng Family of Indexes
Inclusion to MSCI China Indexes
Formation of Lee’s Healthcare Industry Fund L.P. with a maximum fund size of US$20.2 million in August 2015
Successfully raised approximately HK$383 million through the placement of new shares of the Company in April 2015
2014
Formation of China Oncology Focus Limited with the management of the Company
2013
Successfully raised approximately US$10 million through the private placement of series B preferred shares of CVie Therapeutics Company Limited in August 2013
Successfully raised approximately US$3 million through the private placement of series A-2 preferred shares of CVie Therapeutics Company Limited in March 2013
2012
Successfully raised approximately US$4 million through the private placement of series A-1 preferred shares of CVie Therapeutics Company Limited in July 2012
Establishment of China Cardiovascular Focus Limited and CVie Therapeutics Company Limited
Successfully raised approximately HK$152 million through the placement of new shares of the Company to GL Trade Investment Limited in May 2012
2011
Establishment of Guangzhou Zhaoke Lian Fa Medicine Company Limited
2010
Successfully raised approximately HK$40 million through the placement of new shares of the Company to an investor in October 2010
Successfully transfer of listing from GEM to Main Board of the Stock Exchange of Hong Kong Limited (Stock code: 950) on 14 May 2010
Establishment of Powder Pharmaceuticals, Incorporated
2009
Successfully raised approximately HK$19 million through the placement of new shares of the Company to an investor in August 2009
2005
Completed the acquisition of the interests in Zhaoke Pharmaceutical (Hefei) Company Limited from the PRC partner and became a wholly owned subsidiary of the Group
2004
Successfully raised approximately HK$24 million through the placement of new shares and unlisted warrants of the Company to an investor in August 2004
2002
Lee’s Pharmaceutical Holdings Limited announced listing of Initial Public Offering of shares on the Growth Enterprise Market (“GEM”) of the Stock Exchange of Hong Kong Limited and the shares commenced trading on 15 July 2002
1994
Formation of Zhaoke Pharmaceutical (Hefei) Company Limited with a PRC partner, registered and operated in Hefei City, Anhui Province, China
Establishment of the Group in 1994